N. Sorel

发表

Comprehensive characterization of a novel intronic pseudo-exon inserted within an e14/a2 BCR-ABL rearrangement in a patient with chronic myeloid leukemia.

F. Guilhot, N. Sorel, C. Mayeur‐Rousse, 2010, The Journal of molecular diagnostics : JMD.

Superoxide dismutase 2 (SOD2) contributes to genetic stability of native and T315I-mutated BCR-ABL expressing leukemic cells.

A. Bennaceur-Griscelli, L. Tosca, G. Tachdjian, 2018, Biochemical and biophysical research communications.

Table 1. Changes in plasma hCG- and GAPDH mRNA concentrations with therapy in a case with choriocarcinoma. a

N. Sorel, J. Chomel, Florence Chazelas, 2005 .

Double-gradient-denaturing-gradient gel electrophoresis for mutation screening of the BCR-ABL tyrosine kinase domain in chronic myeloid leukemia patients.

N. Sorel, J. Chomel, A. Brizard, 2005, Clinical chemistry.

p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia.

C. Larsen, F. Guilhot, J. Roche, 2003, Blood.

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms.

S. Ragot, L. Christiaens, N. Sorel, 2003, Journal of the American College of Cardiology.

Identification and genetic characterization of a NUP98-HHEX molecular rearrangement in a pediatric acute myeloid leukemia

C. Mecucci, N. Sorel, J. Chomel, 2021, Leukemia & lymphoma.

Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance.

L. Christiaens, N. Sorel, L. Macchi, 2006, Current pharmaceutical design.

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP)

J. Cayuela, C. Preudhomme, M. Tulliez, 2006, Leukemia.

Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuation

J. Bourhis, A. Bennaceur-Griscelli, P. Rousselot, 2016, Oncotarget.

Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors

A. Bennaceur-Griscelli, L. Tosca, G. Tachdjian, 2014, Oncoscience.

ABL-Kinase Mutations in Progenitors and Stem Cells from Chronic Myeloid Leukemia Patients

N. Sorel, A. Turhan, J. Chomel, 2012 .

Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease.

A. Bennaceur-Griscelli, F. Guilhot, N. Sorel, 2011, Blood.

Extensive analysis of the T315I substitution and detection of additional ABL mutations in progenitors and primitive stem cell compartment in a patient with tyrosine kinase inhibitor-resistant chronic myeloid leukemia

F. Guilhot, N. Sorel, L. Roy, 2010, Leukemia & lymphoma.

Consultations in Molecular Diagnostics Comprehensive Characterization of a Novel Intronic Pseudo-Exon Inserted within an e14/a2 BCR-ABL Rearrangement in a Patient with Chronic Myeloid Leukemia

N. Sorel, C. Mayeur‐Rousse, L. Roy, 2010 .

Quantitative monitoring of the T315I mutation in patients with chronic myeloid leukemia (CML).

P. Saulnier, F. Guilhot, N. Sorel, 2009, Leukemia research.

Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemia

F. Guilhot, N. Sorel, C. Mayeur‐Rousse, 2008, Leukemia & lymphoma.

Expression of the cell cycle regulators p14ARF and p16INK4a in chronic myeloid leukemia

C. Larsen, F. Mahon, O. Ayrault, 2006 .

ETV6 (TEL) gene amplification in a myelodysplastic syndrome with excess of blasts

N. Sorel, M. Lessard, B. Lioure, 2004, Leukemia.

Sustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors

X. Leleu, F. Guilhot, N. Sorel, 2018, Leukemia & lymphoma.

Sequential emergence of ABL-kinase mutations with loss of unmutated BCR-ABL allele during targeted therapies of CML.

F. Guilhot, N. Sorel, L. Roy, 2006, Blood.

Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia.

M. Guillier, N. Sorel, A. Turhan, 2004, Biochemical and biophysical research communications.

Longitudinal clonal architecture of acute myeloid leukemia with NPM1 driver insertion, early TET2 mutations and secondary e6a2 BCR-ABL1 rearrangement

X. Leleu, N. Sorel, J. Chomel, 2020, Leukemia & lymphoma.

p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22).

F. Guilhot, N. Sorel, A. Brizard, 2004, Leukemia research.

A rapid and specific whole blood HPA‐1 phenotyping by flow cytometry using two commercialized monoclonal antibodies directed against GP IIIa and GP IIb‐IIIa complexes

L. Christiaens, N. Sorel, S. Brabant, 2004, British journal of haematology.

Long‐term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98‐LEDGF rearrangement

X. Leleu, N. Sorel, J. Chomel, 2019, Cancer medicine.

Evaluation of β-Catenin activating mutations in chronic myeloid leukemia

F. Guilhot, N. Sorel, A. Turhan, 2008 .

A mesenchymal glioma stem cell profile is related to clinical outcome

S. Flamant, U. Cortes, A. Bennaceur-Griscelli, 2014, Oncogenesis.

Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)

A. Bennaceur-Griscelli, C. Desterke, N. Sorel, 2023, Cells.

Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML).

A. Bennaceur-Griscelli, C. Desterke, N. Sorel, 2018, Experimental hematology.

ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia

A. Bennaceur-Griscelli, C. Desterke, N. Sorel, 2021, bioRxiv.

Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model.

S. Flamant, M. Deininger, A. Bennaceur-Griscelli, 2013, Experimental hematology.

Aspirin Resistance Resistance In Vitro to Low-Dose Aspirin Is Associated With Platelet PlA 1 ( GP IIIa ) Polymorphism But Not With C 807 T ( GP Ia / IIa ) and C-5 T Kozak ( GP Ib ) Polymorphisms

S. Ragot, L. Christiaens, N. Sorel, 2016 .

Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate.

L. Christiaens, N. Sorel, S. Brabant, 2002, Thrombosis research.

Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).

K. Tarte, A. Bennaceur-Griscelli, P. Rousselot, 2017, Leukemia research.

Clinical Outcome of 27 Imatinib Mesylate Resistant Chronic Myelogenous Leukemia (CML) Patients Harbouring a T315I BCR-ABL Mutation.

C. Preudhomme, M. Tulliez, S. Hayette, 2006 .

BCR-ABL expression in leukemic progenitors and primitive stem cells of patients with chronic myeloid leukemia.

F. Guilhot, N. Sorel, A. Turhan, 2012, Blood.

Evidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)

J. Bourhis, A. Bennaceur-Griscelli, C. Desterke, 2020, Leukemia & lymphoma.

Evidence of massive leukemic progenitor expansion in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)

J. Bourhis, A. Bennaceur-Griscelli, C. Desterke, 2019, bioRxiv.

The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia.

Julien Pontis, S. Ait-Si-Ali, F. Guilhot, 2015, Experimental hematology.

Stroke and aspirin non-responder patients: Relation with hypertension and platelet response to adenosine diphosphate

S. Ragot, J. Neau, N. Sorel, 2009, Platelets.

C. Preudhomme, F. Guilhot, N. Sorel, 2005, Leukemia & lymphoma.

Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene.

N. Sorel, C. Mayeur‐Rousse, A. Turhan, 2012, Leukemia research.

Evaluation of beta-catenin activating mutations in chronic myeloid leukemia.

F. Guilhot, N. Sorel, A. Turhan, 2008, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model.

S. Flamant, M. Deininger, A. Bennaceur-Griscelli, 2013, Experimental hematology.

Mutation Status of Imatinib Mesylate-Resistants CML Patients and Clinical Outcomes: A French Multicenter Retrospective Study for the fiLMC Group.

C. Preudhomme, S. Hayette, G. Marit, 2004 .

Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with BCR::ABL1 from Chronic Myeloid Leukemia (CML) in Blast Crisis

A. Bennaceur-Griscelli, N. Sorel, A. Turhan, 2023, International journal of molecular sciences.